This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

It’s Nobel Prize season—the time of year when scientists speculate who among them will receive one of the most coveted awards ...

The venture capital firm Atlas Venture is launching a start-up that aims to develop antisense oligonucleotides for a ...

Victor Ambros and Gary Ruvkunreceive prize for the discovery of microRNA and its role in post-transcriptional gene regulation ...

A new study that analyzed 10 inks commonly used in Europe found that 9 of them were out of compliance with the European Union’s Registration, Evaluation, Authorization, and Restriction of ...

Though the topic seems mundane, Jensen tells Newscripts the science is broadly applicable—everyone gets paper cuts—and ...

As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage ...

The ability to alter complex molecules by a single atom at a time would be incredibly useful for medicinal chemistry—it would ...

With the government’s balance of power set to shift after November’s election, the implications for science are far from ...

In the 20th century, corporate powerhouses like Bell Labs and DuPont Central Research funded R&D from their balance sheets, creating a clear path for postdoctoral scientists to innovate beyond ...